Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Weekly Digest
Fed. Cir.

Olaplex, Inc. v. L'Oreal USA, Inc., No. 20-1382 (Fed. Cir. May 6, 2021)

Errata Correction sheet to a previously issued opinion
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 20-1382
Also Docketed
No. 20-1422, No. 20-1689, No. 20-1690 (consolidated; same document)
Decided
May 6, 2021
Judge
Document
Errata
Length
1 page

United States Court of Appeals

for the Federal Circuit

May 7, 2021

ERRATA

Appeal Nos. 2020-1382, 2020-1422, 2020-1689, 2020-1690

OLAPLEX, INC.,

Plaintiff-Cross-Appellant

v.

L’ORÉAL USA, INC., L’ORÉAL USA PRODUCTS,

INC., L’ORÉAL USA S/D, INC., REDKEN 5TH

AVENUE NYC, L.L.C.,

Defendants-Appellants Decided: May 6, 2021

Non-Precedential Opinion

Please make the following change:

On page 4, line 22, “$24,960,00” is changed to “$24,960,000”

Text extracted from the official PDF and reflowed for reading. It is not a certified transcript — the PDF linked above is the authoritative document.

Analysis is coming soon.

A plain-English account of the issues, facts and holding, written by Patent Case Watch. The opinion itself — its full text, its PDF and everything else on this page — stays free to read for everyone, always.

Cite this opinion

Olaplex, Inc. v. L'Oreal USA, Inc., No. 20-1382 (Fed. Cir. May 6, 2021).

govinfo ID
USCOURTS-ca13-20-01382-1
Permalink
https://patentcasewatch.com/opinions/USCOURTS-ca13-20-01382-1

No reporter citation is shown because the official source does not supply one; none is inferred here. Check the opinion and a citator before relying on this form.